Health Marketing Enforcement

Companies can't claim a product treats or cures something without proof, and drug ads must show the risks fairly. FDA and the Federal Trade Commission both send letters when marketing crosses the line. These are those letters, in one list.

585 letters from 2017 to Oct 29, 2026: FDA warning letters that cite marketing claims, letters from FDA's drug promotion office (OPDP), and FTC letters about health products and health care.

• Letters in the last 12 months: 40
• From FDA: 38
• From FTC: 2
• Newest: Oct 29, 2026